Day just after the launch of this campaign, Mexico entered phase two in the pandemic, with 367 confirmed instances. By April 17, it exceeded 1000 deaths and entered phase 3 on April 21. On June 1, the government established a stop-light strategy to define the regional circumstance for the operation of non-essential companies. Meanwhile, within the global scenario, COVAX1 (Berkley 2021; Baker-Sheikh et al. 2021) committed to catering to additional than 150 nations to supply innovative and equitable access to COVID-19 diagnostics, treatments, and vaccines, with 75 countries expressing interest in financing the production of Triadimenol manufacturer vaccines through their public budgets. On 31 July 2020, Mexico was ranked as having the third highest variety of deaths resulting from COVID-19. The WHO named on companies of COVID-19 vaccines to apply for pre-approval and inclusion in the emergency use roll on October 1. Additionally, the WHO and UNICEF made a public call to action to prevent measles and poliomyelitis epidemics due to the interruption of immunization campaigns brought on by COVID-19. The WHO published provisional advice to assist governments develop and renew national action plans on immunization campaigns on November 16. 1 month later (December 11), the Mexican dependency named Comisi Federal para la Protecci Tiaprofenic acid COX contra Riesgos Sanitarios (COFEPRIS, translated as Federal Commission for the Protection against Sanitary Risk) stated their approval for the emergency use of vaccines manufactured by Pfizer and BioNTech. The growing movement and interactions of civilians that accompany the approaching holidays accelerated the every day number of infections. For this reason, Mexico City and Estado de Mexico re-instated the red-stop-light phase on December 18. The very first batch of Pfizer vaccines arrived in the country on December 23, and vaccination efforts for health-related personnel have been initiated the following day. COFEPRIS authorized the emergency use from the Oxford-AstraZeneca vaccine on four January 2021. The government reported that 594,725 vaccines have been administered as of January 22, which amounted to 27, 346 shots on a daily basis. In spite of these favorable results, Mexico reached a total of 20,057 infections on January 23, plus the nation surpassed 150,000 deaths as a result of COVID-19 on January 25. COFEPRIS announced their approval for the Sputnik V vaccine on February 2. Three hundred and seventy-six days after the WHO urged the international population to wear face masks to slow the spread with the disease, the Mexican president announced his rejection of wearing face masks on February eight.Adm. Sci. 2021, 11, x FOR PEER REVIEW4 ofAdm. Sci. 2021, 11,four ofthe Sputnik V vaccine on February two. 3 hundred and seventy-six days after the WHO urged the global population to put on face masks to slow the spread with the illness, the Mexican president announced his rejection of wearing face masks on February 8. On 24 August 2021, according to Statista (2021a), Mexico ranked fourth amongst counOn 24 August 2021, as outlined by Statista (2021a), Mexico ranked fourth among nations with the highest quantity ofof circumstances Latin America, with much more than than 3 million contries using the highest number circumstances in in Latin America, with much more 3 million confirmed instances (Figure 1). firmed situations (Figure 1).Figure 1. Coronavirus (COVID-19) Global Cases by Johns Hopkins CSSE (Statista 2021a).The following section describes the supply and transfer capacities in vaccine distribution. The following section describes the supply and transfer capacities usedu.